The Role of Self-Awareness and Cognitive Dysfunction in Parkinson’s Disease With and Without Impulse-Control Disorder

Relevant conflicts of interest/financial disclosures: RGB has received honoraria for speaking at conferences and educational events from UCB Pharma, GSK, Lundbeck, and is an Advisory Board member for UCB Pharma. MS has received lecture fees from Medtronic, Inc., St. Judes, Inc., unrestricted educational grants from Ipsen and Solvay Pharmaceuticals, and sponsorship for educational meetings from Boehringer Ingelheim. KRC serves as the European Editor of Basal Ganglia, as an editorial board member of Parkinsonism and Related Disorders, and The Journal of Parkinson’s Disease, and, as the Liaison and PR Committee Chairman of the Movement Disorders Society, has received honoraria for academic lectures at sponsored symposiums from UCB Pharma, Britannia, GSK, Abbott, Teva, Medtronic, and Boehringer Ingelheim, and has received educational grants for research from UCB Pharma, Abbott, Boehringer Ingelheim, and Britannia.Funding: The authors acknowledge support from: Parkinson’s UK; Authors RGB and ASD acknowledge support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College, London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.